Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gynecologic 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Paclitaxel 143 pembrolizumab 121 Carboplatin 109 Bevacizumab 93 Cisplatin 69 Specimen Handling 62 olaparib 51 Magnetic Resonance Spectroscopy 51 Gemcitabine 41 Nivolumab 36 Biopsy 36 liposomal doxorubicin 34 Taxes 33 Cyclophosphamide 31 Blood Specimen Collection 31 niraparib 28 lenvatinib 26 Letrozole 26 Doxorubicin 26 Topotecan 25 Drug Therapy 25 Immunoglobulin G 23 Brachytherapy 22 fludarabine 21 atezolizumab 21 Radiotherapy 21 Disulfides 21 durvalumab 20 dostarlimab 19 Surveys and Questionnaires 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Antineoplastic Agents × Gynecologic × 1 year × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡